Annovis Bio is using an AI tool to speed up its FDA filing for buntanetap, a drug aimed at Alzheimer’s and Parkinson’s.

Aged beagle data hint at lower biological age and preliminary muscle changes with SIRT6c treatment, although key readouts ...

As peptides surge in popularity, better evidence and cleaner supply chains could help the field grow without leaving patients ...

Two Lilly candidates posted fresh data in type 2 diabetes, and how the numbers were counted matters as much as the numbers.

Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data ...

Ten innovations spanning diagnostics, AI, mobility, mitochondria and regenerative medicine have been recognized at a Hong Kong summit. Ten organizations, six countries, and very little else in common.

A Tokyo startup called TIME TRAVELER thinks the antiaging answer was sitting in the vegetable drawer all along.

Zsolt Farkas of Evolut on why today's longevity valuations only work if the winners spend the next decade buying everything ...

At ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that ...